Proglumide
- Generic Name
- Proglumide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H26N2O4
- CAS Number
- 6620-60-6
- Unique Ingredient Identifier
- EPL8W5565D
- Indication
用于治疗胃溃疡和十二指肠溃疡、胃炎等，对消化性溃疡临床的改善、溃疡愈合有较好的疗效。
- Associated Conditions
- Gastric Ulcer, Intestinal Inflammation, Intestinal ulcer, Gastrointestinal ulceration
- Associated Therapies
- -
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 30
- Registration Number
- NCT05827055
- Locations
- 🇺🇸
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, United States
Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 32
- Registration Number
- NCT05551858
- Locations
- 🇺🇸
Georgetown University, Washington, District of Columbia, United States
Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 11
- Registration Number
- NCT04814602
- Locations
- 🇺🇸
Georgetown University, Washington, District of Columbia, United States
Safety and Tolerability of Oral Proglumide for NASH
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 18
- Registration Number
- NCT04152473
- Locations
- 🇺🇸
Georgetown University, Washington, District of Columbia, United States
🇺🇸Washington DC Veterans Affairs Medical Center, Washington, District of Columbia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath